Hypothalamic lesions in multiple sclerosis.

Area of Science:

• Neurology
• Immunopathology
• Neuroanatomy

Background:

• Autonomic and endocrine dysfunctions in multiple sclerosis (MS) may stem from demyelinating lesions affecting hypothalamic fiber bundles.
• Investigating these lesions is crucial for understanding MS pathophysiology.

Purpose of the Study:

• To determine the presence and immunological activity of demyelinating lesions within hypothalamic fiber bundles in MS patients.
• To compare hypothalamic lesions with lesions in other brain areas and assess their relationship with disease duration and clinical outcomes.

Main Methods:

• Histopathological examination of hypothalamic tissue from 17 MS patients and 14 controls.
• Assessment of demyelination, axonal damage, grey matter lesions, and Human Leukocyte Antigen (HLA) expression.
• Correlation analysis between lesion load, disease duration, and clinical data.

Main Results:

• 16 of 17 MS patients exhibited demyelinated lesions in hypothalamic fiber bundles.
• Active lesions were prevalent (60%) and outnumbered chronic lesions in the internal capsule.
• Axonal damage and grey matter lesions were observed in a subset of MS patients.
• A significant inverse correlation was found between MS duration and active hypothalamic lesion score (r = -0.72, p = 0.001).
• Hypothalamic lesions in MS patients showed similarity in stage and appearance to lesions in other brain regions.
• Controls lacked demyelinating lesions but showed varying HLA expression, with strong perivascular HLA in the median eminence.

Conclusions:

• The hypothalamus harbors a high incidence of active demyelinating lesions in MS patients, impacting its function.
• These findings highlight the importance of the hypothalamus in MS pathology and suggest its role in disease-related symptoms.
• The study underscores the need for systematic pathological investigation of the hypothalamus in MS research.